ABSTRACT. An eleven-year-old female pug was referred to Yamaguchi University Animal Hospital for evaluation of anemia and thrombocytopenia. The cytological examination of the peripheral blood showed some giant monocytic lineage blast cells. A few granulocytes and platelets had dysplastic features. On day 7, in addition to increasing the monocytic lineage cells, the dysplastic features of the blood had also increased compared to the initial examination. We performed bone marrow aspiration upon her death. The bone marrow revealed dysplastic features in all three hematopoietic cell lines, and an increase in the monocytic cell line. Based on the features of the bone marrow and the peripheral blood, this case was confirmed to be myelodysplastic syndrome-Chronic myelomonocytic leukaemia (MDS-CMML).
Myelodysplastic syndromes (MDSs) are a heterogeneous group of acquired hematological disorders that are characterized by prominent dysplastic features in multiple cell lines in the blood and bone marrow [2, 5, 6, 8, 10] . MDSs are divided into two categories-primary and secondary [13] . The initiating cause of primary MDSs in dogs has not yet been identified [6, 7] , but it is thought to be due to genetic alterations in hematopoietic stem cells [2, 12, 14] . Chronic myelomonocytic leukaemia (CMML) has been defined as one of the types of MDSs in the French-American-British (FAB) system of classification [1] ; however, no case reports have been documented in dogs with MDS-CMML in our best knowledge. This case report describes the clinicopathological features of a dog with suspected MDS-CMML.
An eleven-year-old female pug was referred to Yamaguchi University Animal Hospital for evaluation of progressive anemia and thrombocytopenia which had not responded to seven days treatment with prednisolone (3 mg/ kg, once daily). Upon physical examination, fever (40°C), pale mucous membranes and mild dyspnea were identified (Day 1). Mild bronchitis and splenomegaly were confirmed by radiological examination. The hemogram indicated a normocytic (mean corpuscular volume, 69.5 fl), normochromic (mean corpuscular hemoglobin concentration, 32.7 g/ dl), non-regenerative anemia (hematocrit, 16%, reticulocyte production index, 0.15) and thrombocytopenia (48 × 10 3 / µl). (7 mg/kg, once daily) and blood transfusion as supportive therapy. However, on day 7, the dog's condition worsened and the red blood cell and platelet counts decreased in spite of a blood transfusion administered six days earlier (hematocrit, 15% and platelet counts, 4 × 10 3 /µl). The leukocyte count slightly decreased, but it was still within the normal range (13,450/µl, Table 1 ). In the peripheral blood, the number of promonocytes and monocytes were clearly increased (Table 1 & Fig. 1a) . These monocytic lineage cells stained positive for alpha-naphthyl butyrate esterase (Fig. 1b) with sodium fluoride inhibition (data not shown). The dysplastic features of the blood-lobulated rubricytes (Fig. 1c) , granulocytes with pseudo-Pelger-Huët anomaly and hypersegmentation, large platelets (Fig. 1d) and micromegakaryocytes ( Fig. 1e) -had increased compared to those observed at the initial examination. The patient was administered supportive care, including blood transfusion, but she died on the same day. The cause of her death was not determined because we could not do autopsy. Immediately, upon her death, we performed bone marrow aspiration with the owner's consent. Examination of the bone marrow revealed normocellularity and the ratio of myeloid cells relative to erythroid cells (M: E) was 1.9:1 ( Table 2 & Fig. 2a) . The ratio of blast cells to all nucleated cells (ANC) was 8.5%. There were few mature leukocytes, and an increase in the monocytic lineage cells was observed which accounted for 13.1% of ANC in the bone marrow (Table 2 & Fig. 2b) . The most of mature monocytic lineage cells stained positive for alpha-naphtyrate butyrate esterase with sodium fluoride inhibition. Furthermore, there were certain dysplastic fea- tures in all three hematopoietic cell lines. These dysplastic changes included doughnut-shaped neutrophil precursors (Fig. 2d) , asynchronously maturated rubricytes and rubricytes with multi-nuclei (Fig. 2e) , mononuclear megakaryocytes and micromegakaryocytes. Additionally, macrophage phagocytosis was observed (Fig. 2c) . Based on the features of the bone marrow and the peripheral blood, this case was confirmed to be MDS-CMML.
CMML is classified in the MDSs category by the FAB Cooperative Group, but it has been excluded from the human MDSs classification of the World Health Organization (WHO) scheme [2, 5, 12] . Recently, the WHO system replaced the initial FAB classification for humans due to its improved prognostic discrimination [5] . In the field of veterinary medicine, however, its use has not been critically evaluated in large number of cases [7, 12] . It is also thought that CMML is included in MDSs for its mutilineage dyshematopoiesis and cytopenias, and its high tendency to progress to AML [11] . In this case, in addition to severe erythrocytopenia and thorombocytopenia, the patient had serious dysplastic features in all three cell lines of the blood and bone marrow. Consequently, this case was diagnosed as MDS-CMML based on the FAB system. MDSs are regarded as preleukemic disorders, and some cases that progressed to AML have also been reported in dogs [3, 4, 9, 14, 15] . In the present case, the circulating monocytic lineage cells had been increasing; however, at the time of death, blast cells constituted less than 30% of total marrow cells. Therefore, the condition had not progressed to AML.
In dogs, MDSs tends to progress to AML, and therefore, the prognosis is poor. Although many drugs have been evaluated for the treatment of MDSs an appropriate treatment protocol has not yet been established. More case reports and pilot studies for the treatment are required in the future.
